Skip to content

The Effects of a Probiotic Fermented Milk on Functional Constipation in Adults

The Effects of a Probiotic Fermented Milk on Functional Constipation in Adults

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01161784
Enrollment
100
Registered
2010-07-14
Start date
2010-01-31
Completion date
2010-06-30
Last updated
2010-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Constipation

Keywords

Functional constipation, Probiotic, Probiotic microorganism, Lactobacillus casei Shirota (LcS)

Brief summary

The purpose of this study is to determine the effects of daily consumption for 4 weeks of a fermented milk drink containing a live probiotic microorganism, Lactobacillus casei strain Shirota (LcS) compared to a placebo without LcS, among adults with functional constipation.

Interventions

DIETARY_SUPPLEMENTProbiotics fermented milk

80ml fermented milk containing min. 30 billion live L. casei Shirota strain, administered orally once a day for 4 weeks

DIETARY_SUPPLEMENTNutrient drink

80ml fermented milk without L. casei Shirota strain, administered orally once a day for 4 weeks

Sponsors

University of Malaya
CollaboratorOTHER
National University of Malaysia
CollaboratorOTHER
IMU University, Malaysia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed with functional constipation based on ROME II criteria * Has a constipation severity score (Chinese Constipation Questionnaire or CCQ score) of at least 5, which is the cut-off point for constipated subjects (Chan et al, 2005) * Free of any cardiovascular related diseases, diabetes, cancer, neurological diseases or any other serious illness, not physically or mentally handicapped * Living in Klang Valley, with no pre-determined plans to be out of town for one week or longer during scheduled intervention period

Exclusion criteria

* Body Mass Index of less than 16, or 30 and above * Pregnant * Regular ingestion of probiotic products within the preceding four weeks * Regular use of laxatives (average once a week or more) * Intake of anticholinergics medications or medications against diarrhea or antibiotics in the preceding 1 month * Persons with milk protein allergy * Persons with constipation of organic or neurological origin based on health screening * Persons with alarm features as assessed by physician during health screening

Design outcomes

Primary

MeasureTime frameDescription
Constipation severity score which measures overall signs and symptoms of constipation using the 'Chinese Constipation Questionnaire' or CCQ (Chan et al, 2005)4 weeksConstipation severity score is patient self-assessment of 6 signs and symptoms of constipation: 1. Severity of false alarms 2. Frequency of less than 3 defecations / week 3. Severity of sensation of incomplete bowel movement 4. Severity of lumpy or hard stools 5. Severity of bloating 6. Frequency of laxative use
Frequency of bowel movement4 weeks

Secondary

MeasureTime frameDescription
Stool consistency based on modified Bristol Stool scale4 weeksStool consistency is self-assessed by subjects as Type 1,2,3,4 or 5.
Stool output quantity estimations4 weeksStool output is estimated by subjects visually based on comparison to size of a standard ping pong ball.

Countries

Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026